AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Novonesis AS

Transaction in Own Shares Apr 29, 2011

3377_dirs_2011-04-29_1637420b-5d47-4d22-8517-63e145eae167.pdf

Transaction in Own Shares

Open in Viewer

Opens in native device viewer

April 29, 2011

On February 11, 2011, Novozymes initiated a share buyback program in accordance with the provisions of European Commission Regulation no. 2273/2003 of December 22, 2003, also referred to as the Safe Harbour Regulation.

Under the program Novozymes will buy back B shares for an amount of up to DKK 400 million in the period from February 11, 2011, to December 31, 2011.

The following transactions have been made under the program:

Number of
shares
Average purchase
price
Transaction value,
DKK
Accumulated,
last announcement
126,917 99,386,968
April 15, 2011 2,500 819.85 2,049,625
April 18, 2011 7,500 822.35 6,167,625
April 19, 2011 0 0
April 20, 2011 0 0
April 26, 2011 3,802 827.45 3,145,965
April 27, 2011 3,195 826.23 2,639,805
April 28, 2011 0
Accumulated under the
program
143,914 113,389,988

Transactions related to Novozymes' incentive programs have resulted in a net sale by Novozymes of 4,766 B shares in the period from April 15 to April 28. The shares related to these transactions were not part of the Safe Harbour share buyback program.

With the transactions stated above, Novozymes owns a total of 1,991,555 treasury shares, corresponding to 3.1% of the share capital. The total amount of shares in the company is 65,000,000, including treasury shares.

Contact persons:
Press and media: Investor Relations:
René Tronborg (Europe) Tobias Bjorklund
Tel. (direct): +45 4446 2274
Tel. (mobile): +45 3077 2274
Tel. (direct): +45 4446 8682
Tel. (mobile): +45 3077 8682
Paige Donnelly (USA) Martin Riise Nielsen
Tel. (direct): +1 919 494 3209
Tel. (mobile): +1 919 218 4501
Tel. (direct): +45 4446 0738
Tel. (mobile): +45 3077 0738
Thomas Bomhoff (USA)
Tel. (direct): +1 919 494 3483
Tel. (mobile): +1 919 649 2565

Novozymes is the world leader in bioinnovation. Together with customers across a broad array of industries we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources. Read more at www.novozymes.com.

Company announcement no. 22, 2011 Page 1 of 1 Novozymes A/S Investor Relations

Krogshoejvej 36 2880 Bagsvaerd Denmark

Telephone: +45 4446 0000 Fax: +45 4446 9999 Internet: www.novozymes.com CVR number: 10 00 71 27

Talk to a Data Expert

Have a question? We'll get back to you promptly.